Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorDE PABLOS, Rocio M.
dc.contributor.authorESPINOSA-OLIVA, Ana Maria
hal.structure.identifierUnité de Recherche Oenologie [Villenave d'Ornon] [OENO]
dc.contributor.authorHORNEDO ORTEGA, Ruth
dc.contributor.authorCANO, Mercedes
dc.contributor.authorARGUELLES, Sandro
dc.date.accessioned2020-07-03T08:51:55Z
dc.date.available2020-07-03T08:51:55Z
dc.date.issued2019
dc.identifier.issn1043-6618en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/8536
dc.description.abstractEnAging is a complex process. It is considered a risk factor for several diseases such as cancer, neurodegenerative diseases, cardiovascular diseases, and diabetes, most of which have an oxidative and inflammatory base. Given that life expectancy is increasing, there is a present interest in the search for anti-aging strategies that allow a healthy aging. Interestingly, in Spain, where the Mediterranean Diet (MD) is the reference food pattern, life expectancy will have the highest average by 2040. This diet is characterized, among other items, by virgin olive oil intake, which contains between 50-200 mg/kg of hydroxytyrosol, a major polyphenolic component of olive oil. Hydroxytyrosol is formed by the hydrolysis of oleuropein during the maturing of olives, storage of olive oil, and preparation of table olives. It is a yield of oleuropein by microbiota action in the organism after virgin olive oil consumption. The daily intake in context of the MD is estimated to be around 0.15 and 30 mg/day. In the last few years, hydroxytyrosol has received increasing attention due to its multiple pharmacological activities, such as antioxidant, anti-inflammatory and pro-apoptotic activities. It has also been the focus of extensive research regarding its bioactivity. In this sense, hydroxytyrosol is under consideration for the development of new anti-aging strategies. In this review we will summarize the potential anti-aging effects of hydroxytyrosol and its protective role in several age-related diseases.
dc.language.isoENen_US
dc.subject.enAmpk
dc.subject.enAging
dc.subject.enAutophagy
dc.subject.enHydroxytyrosol
dc.subject.enMediterranean Diet
dc.subject.enSenescence
dc.subject.enSirtuin
dc.title.enHydroxytyrosol protects from aging process via AMPK and autophagy; a review of its effects on cancer, metabolic syndrome, osteoporosis, immune-mediated and neurodegenerative diseases
dc.title.alternativePharmacol. res.en_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.phrs.2019.03.005en_US
dc.subject.halSciences du Vivant [q-bio]/Biologie végétaleen_US
dc.identifier.pubmed30853597en_US
bordeaux.journalPharmacological Researchen_US
bordeaux.page58-72en_US
bordeaux.volume143en_US
bordeaux.hal.laboratoriesOenologie - EA 4577en_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Pharmacological%20Research&rft.date=2019&rft.volume=143&rft.spage=58-72&rft.epage=58-72&rft.eissn=1043-6618&rft.issn=1043-6618&rft.au=DE%20PABLOS,%20Rocio%20M.&ESPINOSA-OLIVA,%20Ana%20Maria&HORNEDO%20ORTEGA,%20Ruth&CANO,%20Mercedes&ARGUELLES,%20Sandro&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée